For: | Andersen NN, Jess T. Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol 2013; 19(43): 7561-7568 [PMID: 24282346 DOI: 10.3748/wjg.v19.i43.7561] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i43/7561.htm |
Number | Citing Articles |
1 |
María A. Nuñez-Sánchez, Rocío García-Villalba, Tamara Monedero-Saiz, Noelia V. García-Talavera, María B. Gómez-Sánchez, Carmen Sánchez-Álvarez, Ana M. García-Albert, Francisco J. Rodríguez-Gil, Miguel Ruiz-Marín, Francisco A. Pastor-Quirante, Francisco Martínez-Díaz, María J. Yáñez-Gascón, Antonio González-Sarrías, Francisco A. Tomás-Barberán, Juan C. Espín. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Molecular Nutrition & Food Research 2014; 58(6): 1199 doi: 10.1002/mnfr.201300931
|
2 |
Wei Dou, Jingjing Zhang, Gaiyan Ren, Lili Ding, Aning Sun, Chao Deng, Xiaojun Wu, Xiaohui Wei, Sridhar Mani, Zhengtao Wang. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation. International Immunopharmacology 2014; 23(1): 170 doi: 10.1016/j.intimp.2014.08.025
|
3 |
Nagwa M. Abdelazeem, Shaimaa A. Gouhar, Cinderella A. Fahmy, Zeinab A. Elshahid, Marwa El-Hussieny. Evaluation of newly synthesized 2-(thiophen-2-yl)-1H-indole derivatives as anticancer agents against HCT-116 cell proliferation via cell cycle arrest and down regulation of miR-25. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68815-8
|
4 |
Taku Maejima, Toru Kono, Fumika Orii, Atsuo Maemoto, Shigeru Furukawa, Wang Liming, Shoji Kasai, Susumu Fukahori, Nobutaka Mukai, Daitaro Yoshikawa, Hidenori Karasaki, Hiroya Saito, Kazuo Nagashima. Anal Canal Adenocarcinoma in a Patient with Longstanding Crohn’s Disease Arising From Rectal Mucosa that Migrated From a Previously Treated Rectovaginal Fistula. American Journal of Case Reports 2016; 17: 448 doi: 10.12659/AJCR.897876
|
5 |
Giulia Santi, Pierre Michetti, Florian Froehlich, Jean-Benoît Rossel, Valérie Pittet, Michel H. Maillard. Adherence to Recommendations and Quality of Endoscopic Colorectal Cancer Surveillance in Long-Standing Ulcerative Colitis. Inflammatory Intestinal Diseases 2021; 6(1): 25 doi: 10.1159/000511010
|
6 |
Peter D R Higgins. Response to Laine et al.. American Journal of Gastroenterology 2015; 110(12): 1735 doi: 10.1038/ajg.2015.362
|
7 |
Patience Mahoro, Hye-Jung Moon, Hee-Jong Yang, Kyung-Ah Kim, Youn-Soo Cha. Protective Effect of Gochujang on Inflammation in a DSS-Induced Colitis Rat Model. Foods 2021; 10(5): 1072 doi: 10.3390/foods10051072
|
8 |
Rosario Fornaro, Michela Caratto, Elisa Caratto, Giuseppe Caristo, Francesco Fornaro, Davide Giovinazzo, Camilla Sticchi, Marco Casaccia, Enzo Andorno. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program. Clinical Colorectal Cancer 2016; 15(3): 204 doi: 10.1016/j.clcc.2016.02.002
|
9 |
Grace Gatenby, Tamara Glyn, John Pearson, Richard Gearry, Tim Eglinton. The long‐term incidence of dysplasia and colorectal cancer in a Crohn’s colitis population‐based cohort. Colorectal Disease 2021; 23(9): 2399 doi: 10.1111/codi.15756
|
10 |
Peng Xu, Zuo Tao, Hua Yang, Cheng Zhang. Obesity and early-onset colorectal cancer risk: emerging clinical evidence and biological mechanisms. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1366544
|
11 |
Hee-Jong Yang, Su-Ji Jeong, Myeong Seon Ryu, Gwangsu Ha, Do-Youn Jeong, Young Mi Park, Hak Yong Lee, Jun Sang Bae. Protective effect of traditional Korean fermented soybean foods (doenjang) on a dextran sulfate sodium-induced colitis mouse model. Food & Function 2022; 13(16): 8616 doi: 10.1039/D2FO01347A
|
12 |
Antonio Altadill, Noemi Eiro, Luis O. González, Alejandro Andicoechea, Silvia Fernández-Francos, Luis Rodrigo, José Luis García-Muñiz, Francisco J. Vizoso. Relationship between Metalloprotease-7 and -14 and Tissue Inhibitor of Metalloprotease 1 Expression by Mucosal Stromal Cells and Colorectal Cancer Development in Inflammatory Bowel Disease. Biomedicines 2021; 9(5): 495 doi: 10.3390/biomedicines9050495
|
13 |
Sofia Saraiva, Isadora Rosa, Joana Moleiro, João Pereira da Silva, Ricardo Fonseca, António Dias Pereira. Dysplasia Surveillance in Inflammatory Bowel Disease: A Cohort Study. GE - Portuguese Journal of Gastroenterology 2021; 28(2): 97 doi: 10.1159/000510728
|
14 |
Vanessa D’Antongiovanni, Matteo Fornai, Carolina Pellegrini, Laura Benvenuti, Corrado Blandizzi, Luca Antonioli. The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia. International Journal of Molecular Sciences 2020; 21(14): 5089 doi: 10.3390/ijms21145089
|
15 |
James Ansell, Fabian Grass, Amit Merchea. Surgical Management of Dysplasia and Cancer in Inflammatory Bowel Disease. Surgical Clinics of North America 2019; 99(6): 1111 doi: 10.1016/j.suc.2019.08.006
|
16 |
Yoon Suk Jung, Minkyung Han, Do Young Kim, Jae Hee Cheon, Sohee Park, James T. Rosenbaum. Cancer risk in Korean patients with Behçet’s disease: A nationwide population-based study. PLOS ONE 2017; 12(12): e0190182 doi: 10.1371/journal.pone.0190182
|
17 |
Hanne R. Hagland, Kjetil Søreide. Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways. Cancer Letters 2015; 356(2): 273 doi: 10.1016/j.canlet.2014.02.026
|
18 |
Yoon Suk Jung, Minkyung Han, Sohee Park, Won Ho Kim, Jae Hee Cheon. Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study. Journal of Crohn's and Colitis 2017; 11(8): 954 doi: 10.1093/ecco-jcc/jjx040
|
19 |
Mariabeatrice Principi, Maria Principia Scavo, Domenico Piscitelli, Vincenzo Villanacci, Rosa Lovero, Giuseppe Losurdo, Bruna Girardi, Enzo Ierardi, Alfredo Di Leo. The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinoma. Scandinavian Journal of Gastroenterology 2015; 50(8): 1002 doi: 10.3109/00365521.2014.978817
|
20 |
Natasa Smrekar, David Drobne, Lojze M. Smid, Ivan Ferkolj, Borut Stabuc, Alojz Ihan, Andreja Natasa Kopitar. Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease. Radiology and Oncology 2018; 52(4): 443 doi: 10.2478/raon-2018-0045
|
21 |
Orsolya Kiraly, Guanyu Gong, Werner Olipitz, Sureshkumar Muthupalani, Bevin P. Engelward, Rosana Risques. Inflammation-Induced Cell Proliferation Potentiates DNA Damage-Induced Mutations In Vivo. PLOS Genetics 2015; 11(2): e1004901 doi: 10.1371/journal.pgen.1004901
|
22 |
Risto J. Rintala, Mikko P. Pakarinen, Antti Koivusalo. Pediatric Surgery. 2020; : 1 doi: 10.1007/978-3-642-38482-0_106-1
|
23 |
Simone Y Loo, Maria Vutcovici, Alain Bitton, Peter L Lakatos, Laurent Azoulay, Samy Suissa, Paul Brassard. Risk of Malignant Cancers in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2019; 13(10): 1302 doi: 10.1093/ecco-jcc/jjz058
|
24 |
|
25 |
Małgorzata Godala, Ewelina Gaszyńska, Konrad Walczak, Ewa Małecka-Wojciesko. Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine 2023; 12(18): 5956 doi: 10.3390/jcm12185956
|
26 |
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen, A Barney Hawthorne. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019; 68(Suppl 3): s1 doi: 10.1136/gutjnl-2019-318484
|
27 |
Mazhar A. Kanak, Yoshitaro Shindo, Pavithra SaiKumar, Bashoo Naziruddin. Inflammasomes: Clinical and Therapeutic Implications. Experientia Supplementum 2018; 108: 235 doi: 10.1007/978-3-319-89390-7_10
|
28 |
Hiroko Nagao-Kitamoto, Sho Kitamoto, Nobuhiko Kamada. Inflammatory bowel disease and carcinogenesis. Cancer and Metastasis Reviews 2022; 41(2): 301 doi: 10.1007/s10555-022-10028-4
|
29 |
Shailja C. Shah, Joana Torres, Steven H. Itzkowitz. Current Common Dilemmas in Colorectal Surgery. 2018; : 43 doi: 10.1007/978-3-319-70117-2_5
|
30 |
Sameen Khalid, Aamer Abbass, Neelam Khetpal, Bo Shen, Udayakumar Navaneethan. Endoscopic detection and resection of dysplasia in inflammatory bowel disease-techniques with videos. International Journal of Colorectal Disease 2019; 34(4): 569 doi: 10.1007/s00384-019-03269-3
|
31 |
Sebastián Eduardo Ibáñez Vodnizza, María Paz Poblete De La Fuente, Elisa Catalina Parra Cancino. Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease. Rheumatic Disease Clinics of North America 2020; 46(2): 275 doi: 10.1016/j.rdc.2020.01.004
|
32 |
Mikolaj Swierczynski, Zuzanna Kasprzak, Adam Makaro, Maciej Salaga. Regulators of G-Protein Signaling (RGS) in Sporadic and Colitis-Associated Colorectal Cancer. International Journal of Molecular Sciences 2024; 25(1): 577 doi: 10.3390/ijms25010577
|
33 |
F. M. L. Fortes, B. C. Silva, B. C. Silva, M. C. Lyra, A. M. Pimentel, G. O. Santana. Gastric Neoplasia during Anti-TNF Therapy for Crohn’s Disease: Casual Event?. Journal of Cancer Therapy 2015; 6(08): 743 doi: 10.4236/jct.2015.68081
|
34 |
Masakazu Yashiro. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2015; 60(8): 2251 doi: 10.1007/s10620-015-3646-4
|
35 |
Christopher G. Chapman, David T. Rubin. The Potential for Medical Therapy to Reduce the Risk of Colorectal Cancer and Optimize Surveillance in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 2014; 24(3): 353 doi: 10.1016/j.giec.2014.03.008
|
36 |
Angelica Nocerino, Alexandra Feathers, Elena Ivanina, Laura Durbin, Arun Swaminath. Mortality Risk of Inflammatory Bowel Disease: A Case–Control Study of New York State Death Records. Digestive Diseases and Sciences 2019; 64(6): 1604 doi: 10.1007/s10620-018-5430-8
|
37 |
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scandinavian Journal of Gastroenterology 2022; 57(5): 513 doi: 10.1080/00365521.2021.2022193
|
38 |
Julie M. Davies, Hong-Uyen Hua, Rishu Dheer, Mitchell Martinez, Sanjoy K. Bhattacharya, Maria T. Abreu, Francesco Cappello. Stool Phospholipid Signature is Altered by Diet and Tumors. PLoS ONE 2014; 9(12): e114352 doi: 10.1371/journal.pone.0114352
|
39 |
Tim R.A. van den Heuvel, Dion S.J. Wintjens, Steven F.G. Jeuring, Maartje H.H. Wassink, Marielle J.L. Romberg‐Camps, Liekele E. Oostenbrug, Silvia Sanduleanu, Wim H. Hameeteman, Maurice P. Zeegers, Ad A. Masclee, Daisy M. Jonkers, Marie J. Pierik. Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population‐based IBDSL cohort. International Journal of Cancer 2016; 139(6): 1270 doi: 10.1002/ijc.30183
|
40 |
Rongjuan Zheng, Jiaheng Ma, Dan Wang, Wenxiao Dong, Sinan Wang, Tianyu Liu, Runxiang Xie, Li Liu, Bangmao Wang, Hailong Cao. Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/1562010
|
41 |
Risto J. Rintala, Mikko P. Pakarinen, Antti Koivusalo. Pediatric Surgery. 2021; : 261 doi: 10.1007/978-3-662-43559-5_106
|
42 |
László Herszényi, Loránd Barabás, Pál Miheller, Zsolt Tulassay. Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk. Digestive Diseases 2015; 33(1): 52 doi: 10.1159/000368447
|
43 |
Mariabeatrice Principi, Michele Barone, Maria Pricci, Nicola De Tullio, Giuseppe Losurdo, Enzo Ierardi, Alfredo Di Leo. Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role?. World Journal of Gastroenterology 2014; 20(33): 11496-11504 doi: 10.3748/wjg.v20.i33.11496
|
44 |
Rishu Dheer, Julie M. Davies, Maria T. Abreu. Intestinal Tumorigenesis. 2015; : 211 doi: 10.1007/978-3-319-19986-3_8
|
45 |
Yijing Ren, Bei Yue, Gaiyan Ren, Zhilun Yu, Xiaoping Luo, Aning Sun, Jingjing Zhang, Mengqing Han, Zhengtao Wang, Wei Dou. Activation of PXR by alantolactone ameliorates DSS-induced experimental colitis via suppressing NF-κB signaling pathway. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53305-z
|
46 |
Anders Mark-Christensen, Søren Laurberg, Najib Haboubi. Dysplasia in Inflammatory Bowel Disease: Historical Review, Critical Histopathological Analysis, and Clinical Implications. Inflammatory Bowel Diseases 2018; 24(9): 1895 doi: 10.1093/ibd/izy075
|
47 |
Hee Man Kim, Ji Hoon Kim, Jung Kuk Lee, Dae Ryong Kang, Hyunil Kim, Su Young Kim, Hyun-Soo Kim. Age- and sex-specific risk of colorectal cancer in incident ulcerative colitis during the first 10 years after diagnosis: a nationwide population-based study. Scandinavian Journal of Gastroenterology 2021; 56(11): 1279 doi: 10.1080/00365521.2021.1958370
|
48 |
SHU-WEI WANG, JUN HU, QIN-HAO GUO, YAN ZHAO, JIE-JING CHENG, DONG-SHENG ZHANG, QIANG FEI, JUAN LI, YUE-MING SUN. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway. Oncology Reports 2014; 32(5): 1991 doi: 10.3892/or.2014.3477
|
49 |
Hee Man Kim, Jihoon Kim, Hyunil Kim, Soon Chang Park, Jung Kuk Lee, Dae Ryong Kang, Su Young Kim, Hyun-Soo Kim. Risk of Gastric Cancer among Patients with Newly Diagnosed Ulcerative Colitis: A Nationwide Population-Based Study. Journal of Clinical Medicine 2023; 12(8): 2843 doi: 10.3390/jcm12082843
|
50 |
Isabel Roitman, Anjali Mone, Arun Swaminath. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; : 171 doi: 10.1007/978-3-030-81780-0_7
|
51 |
T. K. Chattopadhyay. GI Surgery Annual. GI Surgery Annual 2018; 24: 177 doi: 10.1007/978-981-13-0161-2_8
|
52 |
Stephanie A Schubert, Hans Morreau, Noel F C C de Miranda, Tom van Wezel. The missing heritability of familial colorectal cancer. Mutagenesis 2020; 35(3): 221 doi: 10.1093/mutage/gez027
|
53 |
Sandra Cristina Dias dos Santos, Laura Elisabete Ribeiro Barbosa. Crohn's disease: risk factor for colorectal cancer. Journal of Coloproctology 2017; 37(01): 055 doi: 10.1016/j.jcol.2016.06.005
|
54 |
Stephen B. Hanauer, Daniel K. Podolsky. Yamada' s Textbook of Gastroenterology. 2015; : 1378 doi: 10.1002/9781118512074.ch71
|
55 |
Michael J. Hall, Arden M. Morris, Weijing Sun. Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance. American Society of Clinical Oncology Educational Book 2018; (38): 220 doi: 10.1200/EDBK_200961
|
56 |
Jen-Wei Chou, Hsiang-Chun Lai, Chia-Hsi Chang, Ken-Sheng Cheng, Chun-Lung Feng, Tsung-Wei Chen. Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/4175923
|
57 |
柏辉 陈. Risk Factors of Ulcerative Colitis Associated Carcinogenesis and Intervention Progress of Sijunzi Decoction. Traditional Chinese Medicine 2024; 13(05): 963 doi: 10.12677/tcm.2024.135147
|
58 |
Tara M. Connelly, Arthur S. Berg, Leonard R. Harris, David L. Brinton, John P. Hegarty, Sue M. Deiling, David B. Stewart, Walter A. Koltun. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms. Surgery 2014; 156(2): 253 doi: 10.1016/j.surg.2014.03.017
|
59 |
Janina Osman, Sayeh Savari, Naveen Kumar Chandrashekar, Kishan Bellamkonda, Desiree Douglas, Anita Sjölander. Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer. Oncotarget 2017; 8(21): 34773 doi: 10.18632/oncotarget.16718
|
60 |
Jacqueline So, Whitney Tang, Wai Keung Leung, Michael Li, Fu Hang Lo, Marc T. L. Wong, Alex Shun Fung Sze, Chi Man Leung, Steven Woon Choy Tsang, Edwin Hok Shing Shan, Kam Hon Chan, Belsy C. Y. Lam, Aric J. Hui, Wai Hung Chow, Tsz Yiu Lam, Vernon Lam, Tsz Wai Lee, Harris Ho Him Lo, Ching Man Tang, Cheuk Lau Wong, Justin C. Y. Wu, Francis K. L. Chan, Joseph J. Y. Sung, Marcus Harbord, Siew C. Ng. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017; 23(11): 2061 doi: 10.1097/MIB.0000000000001240
|